Holly B. Kordasiewicz, Chief Officer of Ionis Pharmaceuticals IONS, has filed 0 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $4.8M. The latest trade was on 06/12.

HK

HK

Holly B. Kordasiewicz

EVP, Chief Development Officer

Company

Ionis Pharmaceuticals IONS

First filing

26/01/20

Trades

17 trades

Buys / sales

0 / 3

12-month net buying

−$4.8M

Last trade

06/12

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Ionis PharmaceuticalsIONS	Open-market sale10b5-1 plan	06/12	06/16	60,846 sh2 trades	$73.40avg.	$4,466,282.46	−73.0%
Ionis PharmaceuticalsIONS	Open-market sale	01/16	01/20	4,141 sh	$75.66	$313,308.06	−22.0%